+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Lamotrigine"

Bipolar Disorder Therapeutics Market - Global Forecast 2025-2032 - Product Thumbnail Image

Bipolar Disorder Therapeutics Market - Global Forecast 2025-2032

  • Report
  • October 2025
  • 183 Pages
  • Global
From
Bipolar Disorder Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Bipolar Disorder Therapeutics - Global Strategic Business Report

  • Report
  • October 2025
  • 380 Pages
  • Global
From
Bipolar Disorder Drugs and Treatment Market Report 2025 - Product Thumbnail Image

Bipolar Disorder Drugs and Treatment Market Report 2025

  • Report
  • September 2025
  • 250 Pages
  • Global
From
US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026 - Product Thumbnail Image

US Depression Drugs Market, Dosage, Price, Sales Insight 2021-2026

  • Report
  • February 2021
  • 420 Pages
  • United States
From
From
From
  • 7 Results (Page 1 of 1)
Loading Indicator

Lamotrigine is an anticonvulsant drug used to treat mental disorders such as bipolar disorder, depression, and schizophrenia. It is also used to treat seizures in adults and children. Lamotrigine works by stabilizing electrical activity in the brain, which helps to reduce the frequency and severity of seizures and mood swings. It is available in both generic and brand-name forms. The Lamotrigine market is a competitive one, with many companies offering their own versions of the drug. It is widely prescribed by doctors and is generally well-tolerated by patients. Common side effects include dizziness, headache, nausea, and rash. Companies in the Lamotrigine market include GlaxoSmithKline, Pfizer, Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more